A New Look at an Old Option in the Treatment of Early-Stage Prostate Cancer: Hormone Therapy as an Alternative to Watchful Waiting
September 1998
in “
Medical hypotheses
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → Studysummary This article discusses the potential of using flutamide and finasteride for complete androgen blockade in early-stage, low-grade prostate cancer and suggests they may improve symptom-free and overall survival compared to observation.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discussed the potential of hormone therapy as an alternative to watchful waiting in the treatment of early-stage, low-grade prostate cancer. It highlighted the high costs and risks associated with surgery and radiotherapy, which do not show a clear survival benefit over observation. The authors proposed using two oral hormonal agents, flutamide and finasteride, to achieve complete androgen blockade. This approach aimed to address patient concerns about leaving cancer untreated and suggested that hormone therapy might improve symptom-free survival and possibly overall survival.
